Pennington Partners & Co’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Pennington Partners & Co's MRK Position: Q3 2026 in Review
Pennington Partners & Co increased its Merck (MRK) stake by 4.4% in Q3 2026, buying an estimated $16.7K and bringing the position to 2,866 shares worth $419K. The position accounts for 0.13% of the portfolio, ranked #87.
Pennington Partners & Co first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,935 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Pennington Partners & Co held 2,866 shares of Merck worth $419K as of Q3 2026.
- Pennington Partners & Co bought 121 Merck shares in Q3 2026, an estimated $16.7K.
- Merck made up 0.13% of Pennington Partners & Co's portfolio in Q3 2026, its #87 holding.
- Pennington Partners & Co first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
- 3,935 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Pennington Partners & Co's 13F filing for Q3 2026, filed 13 Nov 2026.